Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity
Open Access
- 12 July 2022
- journal article
- research article
- Published by Elsevier BV in Acta Pharmaceutica Sinica. B
- Vol. 13 (5), 2219-2233
- https://doi.org/10.1016/j.apsb.2022.07.004
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Adeno-associated virus capsid antigen presentation is dependent on endosomal escapeJCI Insight, 2013
- Single Amino Acid Modification of Adeno-Associated Virus Capsid Changes Transduction and Humoral Immune ProfilesJournal of Virology, 2012
- Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of AdjuvantsPLOS ONE, 2012
- Efficacy and Safety of Long-term Prophylaxis in Severe Hemophilia A Dogs Following Liver Gene Therapy Using AAV VectorsMolecular Therapy, 2011
- A New Genetic Vaccine Platform Based on an Adeno-Associated Virus Isolated from a Rhesus MacaqueJournal of Virology, 2009
- Cytotoxic-T-Lymphocyte-Mediated Elimination of Target Cells Transduced with Engineered Adeno-Associated Virus Type 2 Vector In VivoJournal of Virology, 2009
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated VirusesJournal of Virology, 2008
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower dosesProceedings of the National Academy of Sciences of the United States of America, 2008
- Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministeredProceedings of the National Academy of Sciences of the United States of America, 2006
- Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapyBlood, 2003